MD Verastem
Verastem Oncology · Verastem, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name MD Verastem as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:14 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07747506 · Continued Access to Avutometinib in Combination With Defactinib in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)Verastem, Inc. · not yet recruiting · Low Grade Ovarian Serous Adenocarcinoma, Ovarian Cancer · study director
- Ph1/Ph2NCT05669482 · Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerVerastem, Inc. · active not recruiting · KRAS Activating Mutation, Metastatic Cancer, Pancreas Cancer · study director
- Ph1/Ph2NCT05375994 · Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC PatientsVerastem, Inc. · completed · Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer · study director
- Ph1/Ph2NCT05074810 · Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC PatientsVerastem, Inc. · active not recruiting · Non Small Cell Lung Cancer, KRAS Activating Mutation · study director
- Ph2NCT04625270 · A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS MutationVerastem, Inc. · active not recruiting · Low Grade Ovarian Serous Adenocarcinoma, Ovarian Cancer · study director
- Ph2NCT04620330 · A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung CancerVerastem, Inc. · completed · Non Small Cell Lung Cancer, KRAS Activating Mutation · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 20:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.